The Enterprise Value as of June 2026 (TTM) for XTL Biopharmaceuticals Ltd. (XTLB) is 5.59M

According to XTL Biopharmaceuticals Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 5.59M. This represents a change of -55.98% compared to the average of 12.70M of the last 4 quarters.

XTL Biopharmaceuticals Ltd. (XTLB) Historical Enterprise Value (quarterly & annually)

How has XTLB Enterprise Value performed in the past?

The mean historical Enterprise Value of XTL Biopharmaceuticals Ltd. over the last ten years is -910759.41. The current 5.59M Enterprise Value has changed -61492.62% with respect to the historical average. Over the past ten years (40 quarters), XTLB's Enterprise Value was at its highest in in the March 2024 quarter at 14.73M. The Enterprise Value was at its lowest in in the March 2017 quarter at -6666789.18.

XTL Biopharmaceuticals Ltd. (XTLB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of XTL Biopharmaceuticals Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

XTL Biopharmaceuticals Ltd. (XTLB) Average Enterprise Value

How has XTLB Enterprise Value performed in the past?

The current Enterprise Value of XTL Biopharmaceuticals Ltd. (XTLB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

XTL Biopharmaceuticals Ltd. (XTLB) Enterprise Value vs. Peers

How is XTLB’s Enterprise Value compared to its peers?

XTL Biopharmaceuticals Ltd.’s Enterprise Value is less than Cyclerion Therapeutics, Inc. (11.25M), less than Polyrizon Ltd. (11.16M), greater than VYNE Therapeutics Inc. (-13823812.00), greater than Alaunos Therapeutics, Inc. (5.17M), greater than AIM ImmunoTech Inc. (139.50K), greater than Quoin Pharmaceuticals, Ltd. (5.31M), greater than Pasithea Therapeutics Corp. (-46001320.00), less than KALA BIO, Inc. (55.91M), less than Radiopharm Theranostics Limited (12.78M), greater than Ensysce Biosciences, Inc. (1.83M),

Build a custom stock screener for XTL Biopharmaceuticals Ltd. (XTLB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like XTL Biopharmaceuticals Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

XTL Biopharmaceuticals Ltd. (XTLB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like XTL Biopharmaceuticals Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.